Business Daily from THE HINDU group of publications
Tuesday, Jan 30, 2007
ePaper


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Industry & Economy - Pharmaceuticals
`Streamline customs norms to boost pharma exports to China'

Our Bureau

FICCI wants non-tariff barriers to go

Advertisement
Bharat Matrimony

New Delhi Jan. 29 To boost India's pharmaceuticals exports to China, the Federation of Indian Chambers of Commerce and Industry (FICCI) has called for streamlining customs procedures and removal of non-tariff barriers.

The chamber suggested that recognition agreements on standards should be arrived at and full details of standards should be made easily available. It also recommended that the various non-tariff barriers such as procedural, legal and cultural barriers be identified, and addressed in a time-bound framework. A bilateral pre-shipment inspection agreement would also benefit both countries, it said.

Deterring factors

It is noteworthy that Indian exports of drug, pharmaceuticals and fine chemicals to markets such as the US, Europe, Africa and South America have grown by 19 per cent annually in the last three years, while the world average growth rate for this sector is about six per cent. In contrast, India's exports to China have grown at just three per cent in the last three years. This indicates that the high-performing Indian pharma sector has not found the environment conducive for achieving similar growth with China, according to the chamber.

Procedures for product and company registration and for procuring import drug licences are expensive and time-consuming. This is a considerable deterrent for Indian entrepreneurs to initiate exports to China, FICCI pointed out.

Long customs procedures, re-inspections and discriminatory packaging and labelling regulations that even specify the colour used for packaging, result in delays and higher costs. Easier trade financing and greater cooperation between the Exim banks of the two countries would also work to the benefit trade between the two countries, according to the chamber.

More Stories on : Pharmaceuticals | Exports & Imports | Industry Associations | Excise and Customs

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Under fog


Flexible rates may instil greater fiscal restraint
Deora leads high-level team to Libya, Yemen
Forging ties
Oscillatory ventilator launched
Five-city debate to finalise stem cell norms
Petronet LNG to sign deal with Aussie co
`Streamline customs norms to boost pharma exports to China'
Ratnagiri Gas wants higher price for power from Dabhol
GMR inks pact with Arunachal for 160 MW hydro power project
Maharashtra tax revenue falls 20 pc in Dec
Plea for VAT return collection centre
Hyundai vendors may set up units near Chennai
Films, piracy and copyright
Blackstone to pick stake in Ushodaya Enterprises
Govt playing safe on maize imports
Auto sector envisages turnover of $145 b by 2016


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line